CVR 39859173Private limited company (ApS)Fremstilling af farmaceutiske præparater (212000)København NFounded 10 Sep 2018
Employees
2
CVR registry, Aug 2026
-1 (-33.3%) over 12 months
Gross profit
-5.5M
DKK, annual report 2025
Result
-7.6M
DKK, annual report 2025
Equity
-20.2M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Cymab ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexEbumab Holding ApSCVR 39807556, 100% of capital and votes, since 10 Sep 2018
Johan Henrik Fabersince 1 Jun 2019
Equity was negative at 31 Dec 2025: -20.2M DKK. Dandex estimate, computed 1 Nov 2026.
CVR 39807556100% of capital and votessince 10 Sep 2018
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
Ultimate controller
Holds 50% to under 66.7% of capital and 66.7% to under 90% of votes in Johan H. Faber ApS, since 5 Dec 2018
Holding company
CVR 40107606Private limited company (ApS)
Holds 50% to under 66.7% of capital and votes in Ebumab Holding ApS, since 1 Jun 2019
Holding company
CVR 39807556Private limited company (ApS)
Holds 100% of capital and votes in Cymab ApS, since 10 Sep 2018
This company
Cymab ApS
CVR 39859173
CVR records founders at incorporation. It does not record whether they are alive or still involved.
10 Sep 2018 to 1 Nov 2026.
10 Sep 2018 to 1 Nov 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Not reported | 0 | Not reported | Not reported | Not reported |
| Gross profit | Not reported | Not reported | -1,206 | -1,952 | -5,463 |
| Operating profit | Not reported | -1,912 | -3,178 | -5,502 | -8,587 |
| Result for the year | -943 | -1,541 | -2,581 | -4,628 | -7,576 |
| Equity | -3,902 | -5,443 | -8,024 | -12,651 | -20,227 |
| Total assets | 383 | 5,166 | 5,556 | 12,611 | 5,779 |
| Employees (average) | 1 | 2 | 2 | 3 | 3 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA | -733note 1 | -1,909 | -3,175 | -5,500 | -8,587 |
| Employee growth (vækst i antal ansatte) | n.m.note 2 | 100% | 0% | 50% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -238 | 415 | 4,787 | 7,845 | 17,859 |
| Capex (investeringer i anlægsaktiver) | 0note 3 | 0note 3 | 0note 3 | 0note 3 | Not reportednote 4 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 3,930 | 5,319 | 9,436 | 12,339 | 21,938 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 25 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 16 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 29 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 30 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 21 Jun 2022
1 registered in CVR.
P-number 1023951386Ole Maaløes Vej 3, 2200 København N
